HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chisato Hosokawa Selected Research

Therapeutics

4/2009Severity scores, itch scores and plasma substance P levels in atopic dermatitis treated with standard topical therapy with oral olopatadine hydrochloride.
4/2008[A case of polyarteritis nodosa successfully treated by rituximab].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chisato Hosokawa Research Topics

Disease

1Atopic Dermatitis (Atopic Eczema)
04/2009
1Dermatomyositis (Dermatopolymyositis)
04/2008
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
04/2008
1Polyarteritis Nodosa (Periarteritis Nodosa)
04/2008
1Rheumatoid Arthritis
04/2008
1Ulcer
04/2008
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
04/2008
1Hemangiosarcoma (Angiosarcoma)
01/2008
1Kasabach-Merritt Syndrome
01/2008

Drug/Important Bio-Agent (IBA)

1Olopatadine Hydrochloride (Patanol)FDA Link
04/2009
1Substance PIBA
04/2009
1Rituximab (Mabthera)FDA Link
04/2008
1Adrenal Cortex Hormones (Corticosteroids)IBA
04/2008

Therapy/Procedure

2Therapeutics
04/2009 - 04/2008
1Blood Component Removal (Apheresis)
04/2008
1Skin Transplantation (Skin Grafting)
04/2008
1Chemoradiotherapy
01/2008